Establishment of a high-risk pediatric AML-derived cell line YCU-AML2 with genetic and metabolic vulnerabilities.
Ikeda J, Shiba N, Kato S, Kunimoto H, Saito Y, Sagisaka M, Ito M, Goto H, Okuno Y, Nakamura W, Yoshitomi M, Takeuchi M, Ito S, Nakajima H, Kato M, Tsujimoto SI.
Ikeda J, et al. Among authors: takeuchi m.
Int J Hematol. 2025 Feb 1. doi: 10.1007/s12185-025-03929-x. Online ahead of print.
Int J Hematol. 2025.
PMID: 39891826